SOLICITATION NOTICE
A -- Addendum 2 to USAID's Global Health BAA (Simplification of Linkage/Delivery of Antiretroviral Therapy in USAID/PEPFAR Programs) - Solicitation
- Notice Date
- 5/29/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Agency for International Development, Washington D.C., USAID/Washington, 1300 Pennsylvania Avenue, NW, Room 7.10-006, Washington, District of Columbia, 20523, United States
- ZIP Code
- 20523
- Solicitation Number
- BAA-OAA-GH-2015
- Archive Date
- 7/7/2015
- Point of Contact
- Courtney J. Magill, Phone: 2025674097
- E-Mail Address
-
cmagill@usaid.gov
(cmagill@usaid.gov)
- Small Business Set-Aside
- N/A
- Description
- Addendum 2 to Global Health's BAA (Simplification of ART) Under this Broad Agency Announcement (BAA) and in support of the United States Agency for International Development’s (USAID) objective to co-create, co-design, co-invest, and collaborate in the development, testing, and scaling of innovative approaches that address critical global health challenges, this addendum (Addendum No. 02) will provide innovative interventions and technologies that further the U.S. Government’s (USG) commitment to prevent and manage a critical global health challenge; the treatment of HIV positive people. In particular, USAID seeks solutions that will bring together promising and proven technologies, innovations, and approaches in the following interrelated areas: 1) Alternative modes of ART delivery such as, but not limited to, community based distribution, technology assisted distribution, and other optimized drug distribution to individuals and the cost-effectiveness of these models 2) Innovative approaches and more effective technologies for viral load monitoring including rapid cost-effective scale up methods for programs which lead to greater efficiencies in training, sample transport, result returns, and quality assurance 3) Use of technology and innovative programmatic strategies to enable more effective linkage activities from diagnosis to treatment, adherence and retention, using community and facility collaboration models for HIV and HIV/TB co-infected individuals 4) Successful care and treatment approaches that directly respond to the needs of key populations as measured by increases in the number of HIV+ individuals in key population groups that are on treatment and retained in care. 5) Promising “Test and Treat” strategies and the cost-effectiveness of models used, as they are brought to scale globally Exploration of new antiretroviral drug regimens that are simpler to use, have a more robust resistance barrier, are less expensive to manufacture, and have other beneficial characteristics to meet the needs of populations in low-income countries, including women and children
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/AID/OP/WashingtonDC/BAA-OAA-GH-2015/listing.html)
- Place of Performance
- Address: Location not yet determined -majority of performance most likely in Africa, United States
- Record
- SN03746802-W 20150531/150529234905-cf9636420cf34e4b1cdda56a9450135b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |